Noncoding variants are a rare cause of recessive developmental disorders in trans with coding variants
Year: 2024
Type: article
Abstract: PURPOSE: Identifying pathogenic noncoding variants is challenging. A single protein-altering variant is often identified in a recessive gene in individuals with developmental disorders (DD), but the prevalence of pathogenic noncoding "second hits" in trans with these is unknown. METHODS: In 4073 genetically undiagnosed rare-disease trio probands from the 100,000 Genomes project, we identified rare heterozygous protein-altering variants in recessive DD-associated genes. We identified rare noncoding variants on the other haplotype in introns, untranslated regions, promoters, and candidate enhancer regions. We clinically evaluated the top candidates for phenotypic fit and performed functional testing where possible. RESULTS: We identified 3761 rare heterozygous loss-of-function or ClinVar pathogenic variants in recessive DD-associated genes in 2430 probands. For 1366 (36.3%) of these, we identified at least 1 rare noncoding variant in trans. Bioinformatic filtering and clinical review, revealed 7 to be a good clinical fit. After detailed characterization, we identified likely diagnoses for 3 probands (in GAA, NPHP3, and PKHD1) and candidate diagnoses in a further 3 (PAH, LAMA2, and IGHMBP2). CONCLUSION: We developed a systematic approach to uncover new diagnoses involving compound heterozygous coding/noncoding variants and conclude that this mechanism is likely to be a rare cause of DDs.
Source: Genetics in Medicine
Institutions: University of Southampton, University of Sheffield, Centre for Human Genetics, University of Oxford, University of Manchester, Wellcome Sanger Institute, University of Washington, Leeds Teaching Hospitals NHS Trust, University of Bristol, University Hospitals Bristol and Weston NHS Foundation Trust, Royal Devon and Exeter Hospital, Royal Devon University Healthcare NHS Foundation Trust, National Health Service, University Hospital Southampton NHS Foundation Trust, National Institute for Health and Care Research, NIHR Southampton Biomedical Research Centre, Broad Institute
Language: English
Topic: Genomics and Rare Diseases
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,490
Awards: Understanding the impact of ‘near-coding’ variation in human disease, Translational genomics- maximising potential for NHS patient care., G3071627590, Wellcome Sanger Institute Quinquennial Review 2021-2026, “We know so much so use us!!” - Improving the treatment for children with GENetic Rare disease: Observational Cohort study (GenROC), G490014172, Wellcome Sanger Institute Quinquennial Review 2021-2026, Understanding the impact of ‘near-coding’ variation in human disease, 4Ward North PhD Programme for Healthcare Professionals
OpenAlex ID: W4402175216
